Seb James, CEO of Boots since 2018, will leave the pharmacy chain in November, as its owner postponed a multibillion-pound sale for the second time.
James will become the group CEO of Veonet, the European ophthalmology clinic chain.
At Boots, he revitalised the beauty sector by introducing new brands, refurbishing beauty halls, and enhancing pharmacy services.
James expressed pride in leading Boots, especially during its 175th year, and praised its impact on UK health and beauty retail.
Walgreens Boots Alliance Inc (NASDAQ:WBA) decided not to sell or float Boots, citing its strategic importance and consistent growth, including recent market share gains.